Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
THANK YOU FOR SUBSCRIBING
Sensiband has been recognized by MedTech Outlook Magazine as the exclusive recipient of “Top 10 Orthopedic Solutions Providers – 2024,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the MedTech Outlook research and editorial team based on insights from an interview with Dr. Mark Drzala, Founder, Sensiband Inventor; Dr. Mitchell Reiter, Founder, Sensiband Inventor.
Dr. Mark Drzala, Founder, Sensiband Inventor; Dr. Mitchell Reiter, Founder, Sensiband Inventor
![]()
Not every doctor is fully allergy-aware; some are simply too busy. Our focus is on helping our customers take control of their health through an affordable, easy-touse solution.


Company
Sensiband
Management
Dr. Mark Drzala, Founder, Sensiband Inventor; Dr. Mitchell Reiter, Founder, Sensiband Inventor and Michael Campagna, COO
Description
Developed by leading doctors, Sensiband offers an affordable, convenient, and non-invasive solution to detect metal allergies. Utilizing harmless skin reactions, this wristband-based kit empowers patients to identify allergies and inform their surgeons for safer implant options.
Sito Web:
mythras.it
Amministratore:
Roberto Livio Mastronardi, co-fondatore
Descrizione:
Mythras è un team di tecnici specializzati nell'assistenza tecnica su strumentazione IVD, esperti nell'aiutare i responsabili di laboratorio a garantire la precisione, l'accuratezza e la conformità dei loro strumenti. È la scelta ideale per numerosi clienti e distributori, al servizio delle loro complesse esigenze di assistenza tecnica e ricondizionamento della strumentazione IVD.
Citazione:
“Siamo certificati ISO 9001:2015 per l'assistenza tecnica e il ricondizionamento della strumentazione analitica IVD.”
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info
